Home . Resources
[Webinar] How to better optimize an oncology drug discovery program
Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.
Read more Financial
Corporate
Financial
07/04/2022
Oncodesign confirms its very good results in 2021 and an attractive outlook for 2022
Read the full press release about our very good results in 2021 & an attractive outlook for 2022 for the group & our BUs Service, Biotech & AI.
Biotech
Financial
08/02/2022
SEngine Precision Medicine & Oncodesign Announce Collaboration Agreement for the Discovery of New Personalized Cancer Treatment
Read all the details of the collaboration agreement for R&D of a new personalized cancer treatment for aggressive and untreatable tumors.
Corporate
Financial
27/01/2022
Oncodesign announces a 2021 turnover of €31.3M, up by 22%, and expects to break even
Find all the 2021 financial information: 2021 turnover of €31.3M, up by 22%, and expects to break even and dive into the BU financial results
Corporate
Financial
05/01/2022
ONCODESIGN announces its 2022 financial agenda
Oncodesign announces all the regulatory dates as far as financial information is concerned. Let's have a look :)
Corporate
Financial
25/10/2021
Oncodesign has appointed Karine Lignel as Group Chief Development Officer
Oncodesign adds a new high-level competence to its COMEX to achieve its external growth objectives with Karine Lignel.
Financial
16/09/2021
Oncodesign announces its results for the first half of 2021
Read all the financial information of Oncodesign and its Business Units Service, Biotech and Artificial Intelligence.
Financial
21/07/2021
Oncodesign announces a sharp increase in turnover in the first half of 2021
Group turnover up by 33% at €15.8M. Despite the global health crisis, which continues to limit international travel...
Corporate
Financial
05/07/2021
Oncodesign announces the appointment of Aline Aubertin as an independent director of the Board of Directors
Oncodesign strenghens its Board by appointing Aline Aubertin as new independent director.
Service
Financial
Oncodesign launches its new DRIVE-MRT™ service offer in partnership with Covalab, CheMatech and ABX-CRO
[Press Release] Explore our brand new service offer DRIVE-MRT. it allows the rationalization, design and optimization of targeted radiopharmaceutical products that are effective against certain metastatic cancers.
Biotech
Financial
24/06/2021
Oncodesign provides an update on its progress on RIPK2
[Press Release] Find the update of the RIPK2 program and the start of new programs associated with Nanocyclix.
Financial
18/06/2021
Oncodesign maintains its revenue and operating income at €38 million in 2020…
[Press Release] Oncodesign maintains its revenue and operating income at €38 million in 2020 and is anticipating an operating profit for the 2nd straight year, within the context of the global public health crisis
A.I
Financial
18/05/2021
InterSystems & Oncodesign partner for the optimization of data use to enhance and accelerate Drug Discovery processes in oncology
Read PRess Release to have an insight on how to organize & leverage healthcare data to accelerate the search for new treatments in oncology using AI.